glp-1 risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Unlocking the broad health benefits
Description
Background Type 2 diabetes mellitus (T2DM) is a chronic condition that affects millions of patients worldwide, posing significant challenges to both patients and healthcare systems
This trend indicates a shift in consumer attitudes towards proactive health management, with GLP-1 drugs being recognized for their dual benefits of weight loss and glycemic control
The program offers compounded GLP-1 injections plus oral drops as a needle-free alternative, served through 503A licensed compounding pharmacies
[DOI] [PMC free article] [PubMed] [Google Scholar] 122
doi:10.1016/j.molmet.2020.101102 Nauck MA et al
notably, the difference between treatment arms was statistically significant in shorter (up to 104 weeks) trials (MHOR 2.28 [1.04, 4.98]
